The House of Angostura® kicks off the countdown to its bicentennial celebrations.
PORT OF SPAIN, Trinidad, Jan. 20, 2024 /PRNewswire/ — The House of Angostura® prepares to celebrate as it counts down to its 200-year anniversary in 2024. With just a few weeks into the start of the new year, the House of Angostura® is ramping up preparations for a full year of festivities i
POLARIS OFF ROAD AND SEBASTIEN LOEB RACING PROVE SUPERIOR WITH RZR PRO R FACTORY, SECURING MONUMENTAL 2024 DAKAR RALLY VICTORY
Xavier de Soultrait and Co-Pilot Martin Bonnet Navigated the Polaris RZR Pro R Factory to Two Stage Wins in Route to the Overall SSV T4 Category Victory MINNEAPOLIS, Jan. 19, 2024 /PRNewswire/ — Polaris Off Road made a triumphant return to the winner’s circle at the 46th Edition of the D
Vet Tix Reaches Historic Milestone of 20+ Million Tickets Distributed to Our Nation’s Heroes
TEMPE, Ariz., Jan. 19, 2024 /PRNewswire/ — Veteran Tickets Foundation (Vet Tix) is ecstatic to announce that the national nonprofit organization has distributed 20+ million free event tickets to our nation’s heroes in cities across America. The value of the tickets is over $1.2 billio
Shareholder Alert: Ademi LLP investigates whether Kaman Corp. has obtained a Fair Price in its transaction with Arcline
MILWAUKEE, Jan. 19, 2024 /PRNewswire/ — Ademi LLP is investigating Kaman (NYSE: KAMN) for possible breaches of fiduciary duty and other violations of law in its transaction with Arcline. Click here to learn how to join the https://www.ademilaw.com/case/kaman-corp or call Guri Ademi toll-free
U.S. Food and Drug Administration Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations
BALVERSA® is the First and Only Targeted Therapy for Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Susceptible Fibroblast Growth Factor Receptor Alterations Phase 3 THOR Study Showed a 36 Percent Reduction in the Risk of Death with BALVERSA® Versus Chemotherapy in Patient
Global Facial Recognition Market Set for Significant Growth to 2030: Widespread Applications Spur Continuous Growth, 3D Recognition Technology Takes the Lead
DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “Global Facial Recognition Market 2030 by Technology, Application, Industry and Region – Partner & Customer Ecosystem Competitive Index & Regional Footprints” report has been added to ResearchAndMarkets.com’s offering.
FEDERAL HOME LOAN BANK OF CINCINNATI WILL OFFER $10.6 MILLION IN GRANTS FOR ACCESSIBILITY AND EMERGENCY REPAIRS
Funds will be used to help low-income homeowners in Kentucky, Ohio and Tennessee CINCINNATI, Jan. 19, 2024 /PRNewswire/ — The Federal Home Loan Bank of Cincinnati (FHLB) will offer $10.6 million in grants to low-income homeowners to fund accessibility rehabilitation and emergency repairs for t
Healthcare technology company, careviso, reaches milestone of 200,000 enrolled providers for prior authorization support
FALLS CHURCH, Va., Jan. 19, 2024 /PRNewswire/ — Health technology company, careviso, reached a remarkable milestone, amassing over 200,000 providers enrolled in their network. The provider enrollment team is responsible for this achievement which comes five years after the company’s inc
Outsell and Foureyes Announce Groundbreaking Strategic Partnership to Transform Dealership Engagement
MINNEAPOLIS , Jan. 19, 2024 /PRNewswire/ — Outsell and Foureyes are thrilled to announce a strategic partnership poised to revolutionize customer engagement in the automotive industry. This collaboration harnesses Foureyes’ groundbreaking technology, integrating seamlessly with Outsell&
PERMIAN BASIN ROYALTY TRUST ANNOUNCES JANUARY CASH DISTRIBUTION
DALLAS, Jan. 19, 2024 /PRNewswire/ — Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) (“Permian” or the “Trust”) today declared a cash distribution to the holders of its units of beneficial interest of $0.031031 per unit, payable on Februa
